Amgen subsidiary Immunex has appealed against a Patent Trial and Appeal Board decision which invalidated a patent claiming antibodies that target human interleukin-4 receptors.
An advocate general has advised the Court of Justice of the European Union on damages in a case between Bayer and pharmaceutical companies Richter and Exeltis.
The European Union has asked the World Trade Organization to initiate dispute consultations with Turkey over requirements imposed by the country on pharmaceutical products.
Chinese companies have entered into a research agreement with scientists in the US and Canada to develop a therapy for neurological disorders by using the natural power of the immune system.
The US Federal Trade Commission has issued a final approval of Fresenius Medical Care’s $2 billion acquisition of medical device company NxStage Medical.
Duane Morris & Selvam has strengthened its IP practice with the addition of John Alison from Winston & Strawn.
Athena Diagnostics has asked the US Federal Circuit to revisit its decision earlier this year, which found four claims in one of its patents to be invalid.
Pharmaceutical companies Alnylam and Regeneron will collaborate on the development and commercialisation of RNA interference therapeutics.
India-based drugmaker Sun Pharma has accused Pfizer of infringing a patent with a new extended-release formulation of Lyrica.
The US Food and Drug Administration and US Customs and Border Protection have strengthened their collaboration in a bid to halt the import of counterfeit drugs and protect public health.